Fundraising Fox
Brent Ahrens
InvestorGeneral Partner at Canaan Partners · Board director at Transposon Therapeutics · Board director at Unchained Labs · Board director at EndoGastric Solutions
Menlo Park, California
Writes $250K – $20M checks · typically $10M
Find your path to Brent
1,275 people in our graph can introduce you to Brent.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Julie Walker to introduce you to Brent
You →Julie · together at Canaan Partners (2017–2019) →Brent
Ask Jamie Chen to introduce you to Brent
You →Jamie · 4 people · together at Canaan Partners →Brent
Ask Sam Okafor to introduce you to Brent
You →Sam · together at Johnson & Johnson →Brent
Sign up to find every way you can get introduced to Brent
- Your email: the people you already email who know Brent
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Brent
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Brent Ahrens, a longtime West Coast healthcare lead since 1999, uniquely combines deep biopharma and medtech investing with a Kauffman Fellows background and active mentorship of new VCs.
Contact· self-published, not guessed
Invests in
BiotechConsumerDeep TechEnterprise SoftwareFintechHardwareHealthtechMedical Devices
Beyond investing
- Education
- Studied at Tuck School of Business at Dartmouth College (MBA) Studied at University of Dayton (BS, Mechanical Engineering)
- Communities
- Ahrens is a member of Kauffman Fellows Class 5, which he completed at Canaan Partners under the mentorship of Harry Rein, and later mentored John Pacifico (Class 12) and Gil Canaani (Class 17).
- Hobbies
- Ahrens is an avid runner and works on home carpentry projects in his spare time.
- More
- Ahrens holds several surgical instrument patents.
From published sources — common ground for a warm intro.
Board director at Transposon Therapeutics
Intro paths
In turn, Brent can intro founders to Transposon Therapeutics's investors below.
Transposon Therapeutics's investors · 2
Board director at Unchained Labs
Intro paths
In turn, Brent can intro founders to Unchained Labs's investors below.
Unchained Labs's investors · 4
Co-founders at Unchained Labs
Board director at EndoGastric Solutions
Intro paths
In turn, Brent can intro founders to EndoGastric Solutions's investors below.
EndoGastric Solutions's investors · 8
Experience
- Canaan PartnersGeneral Partnercurrent2005 — presentSan Francisco Bay Area
- Canaan PartnersPrincipal1999 — 2004Menlo Park/SF
- GSIDirector Business Development and Marketing1997 — 1999Cupertino, CA
- Johnson & JohnsonEngineer1991 — 1995Cincinnati Metropolitan Area
- IAP ResearchEngineer1986 — 1991Dayton Metropolitan Area
Deals · 5
Transposon TherapeuticsBoard seat
via Canaan Partners · filed Dec 2020 · $45.2M raise
Minimally Invasive DevicesBoard seat
via Canaan Partners · filed Nov 2015 · $14.1M raise
Unchained LabsBoard seat
via Canaan Partners · filed Jun 2015 · $31M raise
EndoGastric SolutionsBoard seat
via Canaan Partners · filed Apr 2015 · $1.5M raise
Relievant MedsystemsBoard seat
via Canaan Partners · filed Feb 2015 · $5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
AbyrxAtheroMedCalixa TherapeuticsCerexaCoapt SystemsCoAxiaData Sciences InternationalDexComDurata TherapeuticsElevation PharmaceuticalsGrey Wolf TherapeuticsGrey Wolf TherapeuticsIllumicellIterum TherapeuticsKalidex PharmaceuticalsNovare SurgicalOrthocon, Inc.Pathios TherapeuticsPeninsula PharmaceuticalsRevivantSemnur PharmaceuticalsSpinifex PharmaceuticalsThirtyFiveBio LimitedThirtyFiveBio Limited
Sources: SEC Form D filings · the firm's website · curated public sources.
Colleagues at Canaan Partners
Network5
Investors connected to Brent in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Brent Ahrens?
- Brent Ahrens, a longtime West Coast healthcare lead since 1999, uniquely combines deep biopharma and medtech investing with a Kauffman Fellows background and active mentorship of new VCs.
- Where does Brent Ahrens work?
- Brent Ahrens is General Partner at Canaan Partners and Board director at Transposon Therapeutics and Board director at Unchained Labs and Board director at EndoGastric Solutions.
- What does Brent Ahrens invest in?
- Brent Ahrens invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
- What check size does Brent Ahrens write?
- Brent Ahrens typically writes checks of $250K – $20M.
- What boards does Brent Ahrens sit on?
- Brent Ahrens holds tracked board seats at EndoGastric Solutions, Minimally Invasive Devices, Nexcida Therapeutics, Relievant Medsystems, Transposon Therapeutics, Unchained Labs.
- What companies has Brent Ahrens invested in?
- Investments tracked here include Abyrx, AtheroMed, Calixa Therapeutics, Cerexa, Coapt Systems, CoAxia, Data Sciences International, DexCom, Durata Therapeutics, Elevation Pharmaceuticals, EndoGastric Solutions, Grey Wolf Therapeutics, and 17 more.
- Where did Brent Ahrens go to school?
- Brent Ahrens studied at The Tuck School of Business at Dartmouth (Master of Business Administration - MBA, Finance, Private Equity); University of Dayton (Master's degree, Mechanical Engineering); University of Dayton (Bachelor's degree, Mechanical Engineering).
Same school
Also attended The Tuck School of Business at Dartmouth328
+ 322 more
Also attended University of Dayton63
+ 57 more
Shared employers
Also worked at Canaan Partners45
+ 39 more
Also worked at Johnson & Johnson359
+ 353 more